On Apr. 8, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
On Apr. 8, 2020, Mateon Therapeutics announced that its COVID-19 directed antiviral screening program discovered that Artemisinin is…
![Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
On Apr. 8, 2020, PharmaCyte Biotech announced a license agreement with Hai Kang Life Corp. whereby PharmaCyte received…
On Apr. 8, 2020, Nanomix announced that the company had been awarded $570,000 in funding from Biomedical Advanced…
On Apr. 7, 2020, researchers at the University of Iowa and the University of Georgia announced they had…
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
On Apr. 7, 2020, Cumberland Pharma announced an initiative to increase availability of Vaprisol (conivaptan hydrochloride) injection for…
On Apr. 7, 2020, Mesa Biotech announced it was shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point…
On Apr. 7, 2020, the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application by…
On Apr. 6, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…
On Apr. 6, 2020, Biotest, BPL Group, LFB, and Octapharma joined an alliance formed by CSL Behring and…
On Apr. 6, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
On Apr. 6, 2020, Sema4 announced that it is now performing rapid molecular testing for the detection of…
On Apr. 6, 2020, Inovio Pharma announced the U.S. Food and Drug Administration (FDA) had accepted the company’s…
On Apr. 6, 2020, Mesoblast announced it had received clearance from the U.S. Food and Drug Administration (FDA)…
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
On Apr. 6, 2020, GSK and Vir Biotechnology announced a binding agreement to enter into a collaboration to…
On Apr. 6, 2020, Luminex announced announced that the FDA has issued an Emergency Use Authorization for its…
On Apr. 6, 2020, IGEA Pharma announced that it was starting to supply of a COVID-19 antibody test…
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
On Apr. 6, 2020, Intravacc announced development of an intranasal vaccine against COVID-19 that will be developed through…
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
On Apr. 6, 2020, Mateon Therapeutics announced that it has delivered the requisite testing results to Golden Mountain…